Portfolio of Gene Therapy Stocks
Here are 9 gene therapy stocks. See 10 Most Promising Gene Therapy Companies to Watch.
|9 Portfolio of Gene Therapy Stocks|
Name & Return
|Display Price Chart for each stock.|
|Display Dividend Chart for each stock.|
Portfolio ValuesTo inspect the performance of the Portfolio of Gene Therapy Stocks portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.The 5 stocks included in the portfolio computations are: BLUE, CRSP, EDIT, NTLA and QURE. The current value of the portfolio assumes that $2,000.00 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. The 4 stocks excluded from the portfolio computations because of insufficient price data are: AKUS, BEAM, KRYS and VERV.
The current value of the $10,000 investment is $8,842. The percent return is -11.58%. The annualized return is -2.43%.
Portfolio Value Chart for Last 100 Daily Closes